Marché mondial de la purification des vecteurs viraux – Tendances et prévisions de l’industrie jusqu’en 2031

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Healthcare Global Viral Vector Purification Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché mondial de la purification des vecteurs viraux – Tendances et prévisions de l’industrie jusqu’en 2031

  • Healthcare
  • Upcoming Reports
  • Feb 2024
  • Global
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60
Buy Now Acheter maintenant

Marché mondial de la purification de vecteurs viraux, par produit et services (produits et services), type (vecteurs rétroviraux, virus vaccinaux, vecteurs adénoviraux, vecteurs viraux adéno-associés, lentivirus et autres), flux de travail (traitement en amont et traitement en aval), technique de purification (ultracentrifugation à gradient de densité, ultrafiltration, précipitation, systèmes d'extraction à deux phases et chromatographie), échelle d'opération (préclinique / clinique et commerciale), méthode d'administration (in vivo et ex vivo), indication de maladie (cancer, troubles génétiques, maladies infectieuses, maladie vétérinaire et autres), application (antisens et ARNi, thérapie génique, thérapie cellulaire et vaccinologie), utilisateur final (sociétés de biotechnologie, sociétés pharmaceutiques, organisations de recherche sous contrat, organisation de développement et de fabrication sous contrat (CDMO) et instituts universitaires / de recherche) - Tendances et prévisions de l'industrie jusqu'en 2031.

Marché de la purification des vecteurs viraux

Analyse et taille du marché de la purification des vecteurs viraux

Le marché de la purification des vecteurs viraux progresse rapidement grâce à des technologies innovantes améliorant les processus de purification. Cette évolution comprend de nouvelles techniques de chromatographie, des systèmes à base de membranes et des solutions évolutives pour la production de vecteurs viraux à grande échelle. Ces avancées contribuent à l'isolement et à la purification efficaces des vecteurs viraux, essentiels pour les applications de thérapie génique et de développement de vaccins.                                

Data Bridge Market Research analyse que le marché mondial de la purification des vecteurs viraux, qui était de 721,42 millions USD en 2023, devrait atteindre 2 086,99 millions USD d'ici 2031 et devrait connaître un TCAC de 14,2 % au cours de la période de prévision de 2024 à 2031. Cela indique la valeur marchande. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché de la purification des vecteurs viraux

Rapport métrique

Détails

Période de prévision

2024 à 2031

Année de base

2023

Années historiques

2022 (personnalisable pour 2016-2021)

Unités quantitatives

Chiffre d'affaires en millions USD, volumes en unités, prix en USD

Segments couverts

Product and Services (Products and Services), Type (Retroviral Vectors, Vaccine Virus, Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentivirus and Other), Workflow (Upstream Processing and Downstream Processing), Purification Technique (Density-Gradient Ultracentrifugation, Ultrafiltration, Precipitation, Two-Phase Extraction Systems and Chromatography), Scale of Operation (Preclinical / Clinical and Commercial), Delivery Method (In Vivo and Ex Vivo), Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease and Other), Application (Antisense And RNAi, Gene Therapy, Cell Therapy and Vaccinology), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/ Research Institutes)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Applied Biological Materials Inc. (Canada), Creative Biolabs (U.S.), Bio-Rad Laboratories, Inc. (U.S.), SIRION BIOTECH GmbH (Germany), Merck KGaA (Gemrany), FUJIFILM Diosynth Biotechnologies (U.S.), Batavia Biosciences B.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Addgene (U.S.), IDT Biologika  (Germany), ProBioGen AG (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Waisman Biomanufacturing (U.S.), Creative Biogene (U.S.), Aldevron (U.S.), uniQure N.V. (Netherlands), Cytiva (U.S.) and Sartorius BIA Separations (Solvenia)

Market Opportunities
  • Increasing Clinical Trials Demands for Purified Vectors
  • Emerging Applications into Immunotherapy and Vaccine Development

Market Definition

Viral vector purification is a process aimed at removing impurities and concentrating viral vectors used in gene therapy or vaccine development. It typically involves techniques such as ultracentrifugation, chromatography, and filtration to isolate and purify the viral particles, ensuring safety and efficacy in biomedical applications.            

Global Viral Vector Purification Market Dynamics

Drivers

  • Increasing Demand for Gene Therapy for Chronic Illnesses

The rising incidence of genetic disorders and chronic illnesses is driving a surge in demand for gene therapy. This heightened need is fueling the viral vector purification technologies market, playing a crucial role in addressing a spectrum of medical conditions through efficient isolation and purification processes for gene therapy applications.

  • Advancements in Biotechnology Improving Efficiency and Scalability

Biotechnological advancements are revolutionizing viral vector production, elevating efficiency and scalability. Continuous innovations in bioprocessing techniques and vector engineering are propelling the demand for sophisticated purification methods. This dynamic landscape fosters the development of cutting-edge technologies, ensuring the purification of high-quality viral vectors critical for the success of gene therapies and vaccines.

Opportunities

  • Increasing Clinical Trials Demands for Purified Vectors

The surge in clinical trials for viral vector-based therapies signifies a growing demand for purified vectors, presenting a substantial opportunity for companies specializing in viral vector purification. As the pipeline of therapeutic candidates expands, there's a heightened need for efficient and scalable purification technologies, driving market growth and innovation.

  • Emerging Applications into Immunotherapy and Vaccine Development

The growing utilization of viral vectors in immunotherapy and vaccine development offers a lucrative avenue for purification technologies. The escalating need for reliable and effective vectors in these domains propels market expansion and spurs innovation, positioning purification technologies as indispensable assets in advancing therapeutic and preventive interventions. 

Restraints/Challenges

  • High Purification Costs of Therapies Restricts the Affordability

High purification costs pose a significant barrier to market access for therapies, especially in resource-constrained healthcare settings. The financial burden restricts the affordability and availability of viral vector-based treatments, hindering patient access and adoption, exacerbating healthcare disparities, and impeding market growth.   

  • Complexity in Ensuring Stability of Viral Vector

Viral vector stability poses a significant challenge in the market, as maintaining the integrity of these vectors during purification is complex. Shear forces, temperature variations, and exposure to specific chemicals can compromise their structural integrity, potentially reducing therapeutic efficacy and overall product quality. This instability necessitates rigorous optimization and innovation in purification processes to mitigate these risks and ensure the success of viral vector-based therapies. 

Ce rapport sur le marché mondial de la purification des vecteurs viraux fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et localisé, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans les réglementations du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché mondial de la purification des vecteurs viraux, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché.

Développements récents

  • En janvier 2021, Thermo Fisher Scientific Inc. a finalisé l'acquisition de l'activité de fabrication de vecteurs viraux de Novasep en Belgique. Cette opération stratégique permet à Thermo Fisher d'améliorer ses efforts de diversification du marché, renforçant ainsi sa position dans le domaine en pleine expansion de la production de vecteurs viraux pour la thérapie génique et le développement de vaccins
  • En janvier 2021, Aldevron a élargi son portefeuille de produits en lançant les plasmides rep/cap pALD-AAV2, AAV5 et AAV6 pour soutenir la fabrication de vecteurs viraux AAV. Cet ajout a suscité une augmentation de la demande et des ventes, positionnant l'entreprise pour une croissance future des revenus sur les marchés de la thérapie génique et du développement de vaccins
  • En septembre 2020, Waisman Biomanufacturing a formé un partenariat stratégique avec la société de biotechnologie californienne GigaGen pour développer un nouveau médicament pour le traitement et la prévention du COVID-19. Cette collaboration devrait renforcer le rôle de Waisman Biomanufacturing dans le développement et les tests de médicaments, en renforçant la notoriété de ses services sur le marché pharmaceutique

Portée du marché mondial de la purification des vecteurs viraux

Le marché mondial de la purification des vecteurs viraux est segmenté en fonction du produit et des services, du type, du flux de travail, de la technique de purification, de l'échelle d'opération, de la méthode de distribution, de l'indication de la maladie, de l'application et de l'utilisateur final. La croissance parmi ces segments vous aidera à analyser les segments de croissance maigres dans les industries et fournira aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.

Produits et services

  • Produit
  • Trousse
  • Préemballé
  • Colonne
  • Résine
  • Cassette
  • Capsule
  • Réactif
  • Services

 Taper

  • Vecteurs rétroviraux
  • Virus vaccinal
  • Vecteurs adénoviraux
  • Vecteurs viraux adéno-associés
  • Lentivirus
  • Autre

Flux de travail

  • Traitement en amont
  • Traitement en aval

Technique de purification

  • Ultracentrifugation à gradient de densité
  • Ultrafiltration
  • Précipitation
  • Systèmes d'extraction à deux phases
  • Chromatographie

Échelle d'opération

  • Préclinique / Clinique
  • Commercial

 Méthode de livraison

  • In vivo
  • Ex Vivo

 Indication de la maladie

  • Cancer
  • Troubles génétiques
  • Maladies infectieuses
  • Maladies vétérinaires
  • Autre

 Application

  • Antisens et ARNi
  • Thérapie génique
  • Thérapie cellulaire
  • Vaccinologie

 Utilisateur final

  • Sociétés de biotechnologie
  • Sociétés pharmaceutiques
  • Organismes de recherche sous contrat
  • Organisation de développement et de fabrication sous contrat (CDMO)
  • Instituts universitaires/de recherche

Analyse/perspectives régionales du marché mondial de la purification des vecteurs viraux

Le marché mondial de la purification des vecteurs viraux est analysé et des informations et tendances sur la taille du marché sont fournies par pays, produit et services, type, flux de travail, technique de purification, échelle d'opération, méthode de distribution, indication de maladie, application et utilisateur final comme référencé ci-dessus.

Les pays couverts dans le rapport sur le marché mondial de la purification des vecteurs viraux sont les États-Unis, le Canada et le Mexique en Amérique du Nord, l'Allemagne, la France, le Royaume-Uni, les Pays-Bas, la Suisse, la Belgique, la Russie, l'Italie, l'Espagne, la Turquie, le reste de l'Europe en Europe, la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), l'Arabie saoudite, les Émirats arabes unis, l'Afrique du Sud, l'Égypte, Israël, le reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), le Brésil, l'Argentine et le reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud.

L'Amérique du Nord devrait dominer le marché de la purification des vecteurs viraux, grâce à son adoption généralisée par les patients. Les États-Unis sont en tête de cette croissance dans la région, propulsés par une présence significative d'acteurs clés du marché. Cette domination souligne le rôle central de l'Amérique du Nord dans l'avancement des technologies et des thérapies de purification des vecteurs viraux.

L’Europe devrait dominer le marché de la purification des vecteurs viraux entre 2024 et 2031, grâce à son infrastructure de soins de santé avancée et à l’augmentation des investissements dans ce secteur. L’Allemagne apparaît comme une force dominante au sein du secteur européen, propulsée par les progrès continus des technologies de purification des vecteurs viraux.

L'Asie-Pacifique devrait dominer le marché de la purification des vecteurs viraux, affichant le taux de croissance annuel composé (TCAC) le plus rapide au cours de la période de prévision. La croissance démographique de la région et l'augmentation des dépenses de santé entraînent une demande croissante. Le Japon, pionnier dans l'utilisation de produits avancés de purification des vecteurs viraux, devrait dominer le marché en Asie-Pacifique.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Croissance des infrastructures de santé Base installée et pénétration des nouvelles technologies

Le marché mondial de la purification des vecteurs viraux vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché mondial de la purification des vecteurs viraux, l'impact de la technologie utilisant des courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché mondial de la purification des vecteurs viraux. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et des parts de marché mondiales de la purification des vecteurs viraux

Le paysage concurrentiel du marché mondial de la purification des vecteurs viraux fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial de la purification des vecteurs viraux.

Certains des principaux acteurs opérant sur le marché mondial de la purification des vecteurs viraux sont :

  • Matériaux Biologiques Appliqués Inc. (Canada)
  •  Creative Biolabs (États-Unis)
  •  Bio-Rad Laboratories, Inc. (États-Unis)
  •  SIRION BIOTECH GmbH (Allemagne)
  • Merck KGaA (Allemagne)
  •  FUJIFILM Diosynth Biotechnologies (États-Unis)
  •  Batavia Biosciences BV (Pays-Bas)
  •  Agilent Technologies, Inc. (États-Unis)
  •  Addgene (États-Unis)
  • IDT Biologika (Allemagne)
  •  ProBioGen AG (Allemagne)
  •  Takara Bio Inc. (Japon)
  • Thermo Fisher Scientific Inc. (États-Unis)
  • Waisman Biomanufacturing (États-Unis)
  •  Creative Biogene (États-Unis)
  •  Aldevron (États-Unis)
  •  uniQure NV (Pays-Bas)
  •  Cytiva (États-Unis)
  • Séparations BIA Sartorius (Slovénie)

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL viral vector purification market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET application COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Market Overview
    1. drivers
      1. Rising demand for viral vectors
      2. Availability of diverse range of innovative solutions for vector purification
      3. Emergence of COVID-19 and demand for vaccine development
      4. Benefits of Viral vectors for gene therapy
      5. Growing usage of AAV vectors for delivery of siRNA in mammalian cells
    2. Restraints
      1. lack of scalability
      2. Limitations of downstream purification
    3. OPPORTUNITIES
      1. GROWING CANCER BURDEN WORLDWIDE
      2. RISING NUMBER OF INFECTIOUS DISEASES
      3. GROWING GERIATRIC POPULATION
      4. RISING HEALTH CONSCIOUSNESS AND INCREASING SPENDING ON HEALTHCARE
    4. CHALLENGES
      1. BIOLOGICAL CHALLENGES
      2. SHORTAGE OF SKILLED PERSONNEL
  5. GLOBAL VIRAL VECTOR PURIFICATION MARKET: REGULATIONS
  6. Global Viral vector purification market, By product & services
    1. overview
    2. products
      1. Resin
      2. Kit
      3. Reagent
      4. Prepacked Column
      5. Cassette
      6. Capsule
      7. Filter Plate
    3. services
  7. Global Viral vector purification market, By purification technique
    1. overview
    2. Chromatography
      1. Affinity Chromatography
      2. Ion-Exchange Chromatography
      3. Size-Exclusion Chromatography
      4. Hydrophilic Interaction Chromatography
    3. Density-Gradient Ultracentrifugation
    4. Ultrafiltration
    5. Precipitation
    6. Two-Phase Extraction Systems
  8. Global Viral vector purification market, By type
    1. overview
    2. Adeno-Associated Viral Vectors
    3. Adenoviral Vectors
      1. Mastadenovirus
      2. Aviadenovirus
      3. Siadenovirus
      4. Atadenovirus
      5. Ichtadenovirus
    4. Lentivirus
    5. Retroviral Vectors
      1. Replication Defective
      2. Replication-Competent
    6. Vaccine Virus
    7. Other
  9. Global Viral vector purification market, By workflow
    1. overview
    2. Upstream Processing
    3. Downstream Processing
  10. Global Viral vector purification market, By scale of operation
    1. overview
    2. Preclinical / Clinical
    3. Commercial
  11. Global Viral vector purification market, By delivery mode
    1. overview
    2. In Vivo
    3. Ex Vivo
  12. Global Viral vector purification market, By Disease Indication
    1. overview
    2. Genetic Disorders
      1. Thalassemia
      2. Cystic Fibrosis
      3. Tay-Sachs Disease
      4. Sickle Cell Anemia
      5. Others
    3. Infectious Diseases
      1. Measles Virus
      2. Vesicular Stomatitis Virus
      3. Novel Adenoviruses
      4. Cytomegalovirus
      5. Others
    4. Veterinary Disease
    5. CANCER
    6. OTHER
  13. Global Viral vector purification market, By Application
    1. overview
    2. Gene Therapy
      1. Recombinant Protein Expression
      2. Functional Assays
      3. Protein Characterization
      4. In Vitro Transcription
      5. Others
    3. cell Therapy
    4. Vaccinology
    5. Antisense & RNAi
  14. Global Viral vector purification market, By end user
    1. overview
    2. Academic/ Research Institutes
    3. Pharmaceutical Companies
    4. Contract Development and Manufacturing Organization (CDMO)
    5. Biotechnology Companies
    6. Contract Research Organizations
  15. GLOBAL VIRAL VECTOR PURIFICATION MARKET, BY GEOGRAPHY
    1. Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. GERMANY
      2. France
      3. U.K.
      4. ITALY
      5. SPAIN
      6. Netherlands
      7. Belgium
      8. Switzerland
      9. Russia
      10. Turkey
      11. Rest of Europe
    4. Asia-Pacific
      1. Japan
      2. South Korea
      3. Australia
      4. Singapore
      5. Malaysia
      6. Thailand
      7. Indonesia
      8. Philippines
      9. Rest of Asia-Pacific
    5. Middle EAST & AFRICA
      1. SOUTH AFRICA
      2. Saudi Arabia
      3. UAE
      4. EGYPT
      5. ISRAEL
      6. rest of Middle East & Africa
    6. South America
      1. Brazil
      2. argentina
      3. rest of south america
  16. Global Viral Vector Purification Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  17. COMPANY PROFILE
    1. THERMO FISHER SCIENTIFC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Cytiva (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    3. Merck KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. Agilent Technologies, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. FUJIFILM Diosynth Biotechnologies
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
    6. addgene
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. aldevron
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Applied Biological Materials Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. BIA Separations
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. BIO-RAD LABORATORIES, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. BioVision Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. Batavia Biosciences B.V.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Creative Biogene
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. Creative Biolabs
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
    15. IDT Biologika GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. ProBioGen AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. Sirion-Biotech GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. TAKARA BIO INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. uniQure N.V.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. Waisman Biomanufacturing
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  18. questionnaire
  19. related reports

Liste des tableaux

TABLE 1 Global Viral vector purification market, By product & services, 2019-2028 (USD million)

TABLE 2 Global Products in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 3 Global Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 4 Global Services in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 5 Global Viral vector purification market, By purification technique, 2019-2028 (USD million)

TABLE 6 Global Chromatography in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 7 Global Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 8 Global Density-Gradient Ultracentrifugation in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 9 Global Ultrafiltration in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 10 Global Precipitation in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 11 Global Two-Phase Extraction Systems in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 12 Global Viral vector purification market, By type, 2019-2028 (USD million)

TABLE 13 Global Adeno-Associated Viral Vectors in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 14 Global Adenoviral Vectors in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 15 Global Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 16 Global Lentivirus in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 17 Global Retroviral Vectors in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 18 Global Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 19 Global Vaccine Virus in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 20 Global other in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Viral vector purification market, By workflow, 2019-2028 (USD million)

TABLE 22 Global Upstream Processing in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Downstream Processing in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 24 Global Viral vector purification market, By scale of operation, 2019-2028 (USD million)

TABLE 25 Global Preclinical / Clinical in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global Commercial in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 27 Global Viral vector purification market, By delivery mode, 2019-2028 (USD million)

TABLE 28 Global In Vivo in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 29 Global Ex Vivo in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Viral vector purification market, By Disease Indication, 2019-2028 (USD million)

TABLE 31 Global Genetic Disorders in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 33 Global Infectious Diseases in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 34 Global Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 35 Global Veterinary Disease in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 36 Global Cancer in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 37 Global Other in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 38 Global Viral vector purification market, By Application, 2019-2028 (USD million)

TABLE 39 Global Gene Therapy in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 40 Global Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 41 Global Cell Therapy in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 42 Global Vaccinology in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 43 Global Antisense & RNAi in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 44 Global Viral vector purification market, By end user, 2019-2028 (USD million)

TABLE 45 Global Academic/ Research Institutes in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 46 Global Pharmaceutical Companies in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 47 Global Contract Development and Manufacturing Organization (CDMO) in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 48 Global Biotechnology Companies in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 49 Global Contract Research Organizations in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 50 GLOBAL VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 North America viral vector purification Market, By COUNTRY, 2021-2028 (USD million)

TABLE 52 North America Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 53 North America Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 54 North America Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 55 North America Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 56 North America Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 57 North America Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 58 North America Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 59 North America Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 60 North America Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 61 North America Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 62 North America Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 63 North America Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 64 North America Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 65 North America Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 66 North America Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 67 North America Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 68 U.S. Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 69 U.S. Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 70 U.S. Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 71 U.S. Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 72 U.S. Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 73 U.S. Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 74 U.S. Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 75 U.S. Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 76 U.S. Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 77 U.S. Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 78 U.S. Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 79 U.S. Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 80 U.S. Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 81 U.S. Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 82 U.S. Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 83 U.S. Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 84 Canada Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 85 Canada Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 86 Canada Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 87 Canada Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 88 Canada Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 89 Canada Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 90 Canada Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 91 Canada Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 92 Canada Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 93 Canada Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 94 Canada Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 95 Canada Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 96 Canada Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 97 Canada Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 98 Canada Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 99 Canada Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 100 Mexico Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 101 Mexico Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 102 Mexico Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 103 Mexico Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 104 Mexico Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 105 Mexico Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 106 Mexico Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 107 Mexico Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 108 Mexico Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 109 Mexico Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 110 Mexico Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 111 Mexico Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 112 Mexico Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 113 Mexico Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 114 Mexico Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 115 Mexico Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 116 EUROPE viral vector purification Market, By COUNTRY, 2021-2028 (USD million)

TABLE 117 EUROPE Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 118 Europe Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 119 Europe Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 120 Europe Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 121 Europe Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 122 Europe Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 123 Europe Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 124 Europe Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 125 Europe Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 126 Europe Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 127 Europe Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 128 Europe Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 129 Europe Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 130 Europe Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 131 Europe Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 132 Europe Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 133 Germany Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 134 Germany Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 135 Germany Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 136 Germany Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 137 Germany Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 138 Germany Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 139 Germany Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 140 Germany Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 141 Germany Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 142 Germany Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 143 Germany Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 144 Germany Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 145 Germany Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 146 Germany Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 147 Germany Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 148 Germany Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 149 France Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 150 France Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 151 France Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 152 France Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 153 France Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 154 France Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 155 France Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 156 France Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 157 France Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 158 France Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 159 France Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 160 France Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 161 France Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 162 France Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 163 France Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 164 France Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 165 U.K. Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 166 U.K. Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 167 U.K. Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 168 U.K. Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 169 U.K. Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 170 U.K. Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 171 U.K. Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 172 U.K. Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 173 U.K. Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 174 U.K. Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 175 U.K. Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 176 U.K. Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 177 U.K. Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 178 U.K. Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 179 U.K. Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 180 U.K. Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 181 Italy Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 182 Italy Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 183 Italy Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 184 Italy Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 185 Italy Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 186 Italy Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 187 Italy Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 188 Italy Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 189 Italy Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 190 Italy Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 191 Italy Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 192 Italy Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 193 Italy Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 194 Italy Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 195 Italy Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 196 Italy Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 197 Spain Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 198 Spain Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 199 Spain Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 200 Spain Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 201 Spain Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 202 Spain Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 203 Spain Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 204 Spain Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 205 Spain Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 206 Spain Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 207 Spain Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 208 Spain Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 209 Spain Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 210 Spain Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 211 Spain Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 212 Spain Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 213 Netherlands Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 214 Netherlands Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 215 Netherlands Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 216 Netherlands Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 217 Netherlands Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 218 Netherlands Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 219 Netherlands Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 220 Netherlands Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 221 Netherlands Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 222 Netherlands Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 223 Netherlands Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 224 Netherlands Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 225 Netherlands Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 226 Netherlands Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 227 Netherlands Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 228 Netherlands Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 229 Belgium Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 230 Belgium Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 231 Belgium Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 232 Belgium Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 233 Belgium Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 234 Belgium Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 235 Belgium Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 236 Belgium Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 237 Belgium Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 238 Belgium Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 239 Belgium Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 240 Belgium Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 241 Belgium Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 242 Belgium Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 243 Belgium Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 244 Belgium Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 245 Switzerland Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 246 Switzerland Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 247 Switzerland Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 248 Switzerland Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 249 Switzerland Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 250 Switzerland Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 251 Switzerland Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 252 Switzerland Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 253 Switzerland Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 254 Switzerland Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 255 Switzerland Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 256 Switzerland Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 257 Switzerland Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 258 Switzerland Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 259 Switzerland Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 260 Switzerland Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 261 Russia Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 262 Russia Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 263 Russia Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 264 Russia Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 265 Russia Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 266 Russia Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 267 Russia Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 268 Russia Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 269 Russia Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 270 Russia Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 271 Russia Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 272 Russia Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 273 Russia Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 274 Russia Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 275 Russia Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 276 Russia Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 277 Turkey Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 278 Turkey Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 279 Turkey Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 280 Turkey Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 281 Turkey Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 282 Turkey Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 283 Turkey Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 284 Turkey Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 285 Turkey Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 286 Turkey Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 287 Turkey Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 288 Turkey Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 289 Turkey Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 290 Turkey Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 291 Turkey Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 292 Turkey Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 293 Rest of Europe Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 294 Asia-Pacific viral vector purification Market, By COUNTRY, 2021-2028 (USD million)

TABLE 295 Asia-Pacific Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 296 Asia-Pacific Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 297 Asia-Pacific Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 298 Asia-Pacific Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 299 Asia-Pacific Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 300 Asia-Pacific Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 301 Asia-Pacific Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 302 Asia-Pacific Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 303 Asia-Pacific Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 304 Asia-Pacific Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 305 Asia-Pacific Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 306 Asia-Pacific Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 307 Asia-Pacific Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 308 Asia-Pacific Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 309 Asia-Pacific Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 310 Asia-Pacific Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 311 Japan Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 312 Japan Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 313 Japan Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 314 Japan Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 315 Japan Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 316 Japan Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 317 Japan Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 318 Japan Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 319 Japan Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 320 Japan Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 321 Japan Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 322 Japan Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 323 Japan Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 324 Japan Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 325 Japan Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 326 Japan Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 327 China Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 328 China Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 329 China Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 330 China Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 331 China Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 332 China Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 333 China Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 334 China Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 335 China Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 336 China Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 337 China Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 338 China Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 339 China Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 340 China Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 341 China Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 342 China Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 343 India Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 344 India Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 345 India Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 346 India Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 347 India Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 348 India Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 349 India Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 350 India Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 351 India Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 352 India Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 353 India Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 354 India Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 355 India Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 356 India Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 357 India Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 358 India Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 359 South Korea Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 360 South Korea Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 361 South Korea Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 362 South Korea Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 363 South Korea Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 364 South Korea Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 365 South Korea Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 366 South Korea Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 367 South Korea Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 368 South Korea Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 369 South Korea Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 370 South Korea Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 371 South Korea Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 372 South Korea Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 373 South Korea Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 374 South Korea Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 375 Australia Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 376 Australia Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 377 Australia Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 378 Australia Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 379 Australia Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 380 Australia Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 381 Australia Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 382 Australia Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 383 Australia Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 384 Australia Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 385 Australia Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 386 Australia Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 387 Australia Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 388 Australia Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 389 Australia Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 390 Australia Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 391 Singapore Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 392 Singapore Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 393 Singapore Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 394 Singapore Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 395 Singapore Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 396 Singapore Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 397 Singapore Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 398 Singapore Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 399 Singapore Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 400 Singapore Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 401 Singapore Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 402 Singapore Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 403 Singapore Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 404 Singapore Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 405 Singapore Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 406 Singapore Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 407 Malaysia Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 408 Malaysia Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 409 Malaysia Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 410 Malaysia Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 411 Malaysia Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 412 Malaysia Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 413 Malaysia Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 414 Malaysia Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 415 Malaysia Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 416 Malaysia Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 417 Malaysia Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 418 Malaysia Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 419 Malaysia Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 420 Malaysia Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 421 Malaysia Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 422 Malaysia Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 423 Thailand Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 424 Thailand Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 425 Thailand Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 426 Thailand Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 427 Thailand Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 428 Thailand Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 429 Thailand Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 430 Thailand Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 431 Thailand Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 432 Thailand Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 433 Thailand Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 434 Thailand Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 435 Thailand Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 436 Thailand Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 437 Thailand Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 438 Thailand Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 439 Indonesia Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 440 Indonesia Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 441 Indonesia Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 442 Indonesia Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 443 Indonesia Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 444 Indonesia Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 445 Indonesia Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 446 Indonesia Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 447 Indonesia Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 448 Indonesia Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 449 Indonesia Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 450 Indonesia Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 451 Indonesia Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 452 Indonesia Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 453 Indonesia Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 454 Indonesia Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 455 Philippines Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 456 Philippines Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 457 Philippines Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 458 Philippines Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 459 Philippines Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 460 Philippines Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 461 Philippines Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 462 Philippines Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 463 Philippines Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 464 Philippines Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 465 Philippines Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 466 Philippines Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 467 Philippines Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 468 Philippines Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 469 Philippines Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 470 Philippines Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 471 Rest of Asia-Pacific Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 472 MIDDLE EAST & AFRICA viral vector purification Market, By COUNTRY, 2021-2028 (USD million)

TABLE 473 MIDDLE EAST & AFRICA Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 474 Middle East & Africa Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 475 Middle East & Africa Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 476 Middle East & Africa Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 477 Middle East & Africa Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 478 Middle East & Africa Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 479 Middle East & Africa Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 480 Middle East & Africa Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 481 Middle East & Africa Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 482 Middle East & Africa Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 483 Middle East & Africa Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 484 Middle East & Africa Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 485 Middle East & Africa Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 486 Middle East & Africa Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 487 Middle East & Africa Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 488 Middle East & Africa Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 489 South Africa Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 490 South Africa Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 491 South Africa Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 492 South Africa Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 493 South Africa Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 494 South Africa Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 495 South Africa Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 496 South Africa Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 497 South Africa Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 498 South Africa Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 499 South Africa Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 500 South Africa Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 501 South Africa Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 502 South Africa Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 503 South Africa Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 504 South Africa Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 505 Saudi Arabia Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 506 Saudi Arabia Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 507 Saudi Arabia Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 508 Saudi Arabia Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 509 Saudi Arabia Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 510 Saudi Arabia Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 511 Saudi Arabia Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 512 Saudi Arabia Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 513 Saudi Arabia Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 514 Saudi Arabia Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 515 Saudi Arabia Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 516 Saudi Arabia Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 517 Saudi Arabia Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 518 Saudi Arabia Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 519 Saudi Arabia Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 520 Saudi Arabia Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 521 UAE Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 522 UAE Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 523 UAE Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 524 UAE Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 525 UAE Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 526 UAE Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 527 UAE Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 528 UAE Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 529 UAE Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 530 UAE Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 531 UAE Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 532 UAE Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 533 UAE Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 534 UAE Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 535 UAE Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 536 UAE Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 537 Egypt Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 538 Egypt Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 539 Egypt Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 540 Egypt Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 541 Egypt Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 542 Egypt Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 543 Egypt Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 544 Egypt Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 545 Egypt Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 546 Egypt Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 547 Egypt Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 548 Egypt Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 549 Egypt Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 550 Egypt Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 551 Egypt Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 552 Egypt Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 553 Israel Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 554 Israel Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 555 Israel Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 556 Israel Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 557 Israel Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 558 Israel Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 559 Israel Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 560 Israel Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 561 Israel Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 562 Israel Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 563 Israel Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 564 Israel Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 565 Israel Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 566 Israel Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 567 Israel Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 568 Israel Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 569 rest of Middle East & Africa Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 570 South America viral vector purification Market, By COUNTRY, 2021-2028 (USD million)

TABLE 571 South America Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 572 South America Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 573 South America Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 574 South America Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 575 South America Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 576 South America Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 577 South America Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 578 South America Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 579 South America Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 580 South America Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 581 South America Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 582 South America Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 583 South America Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 584 South America Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 585 South America Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 586 South America Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 587 Brazil Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 588 Brazil Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 589 Brazil Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 590 Brazil Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 591 Brazil Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 592 Brazil Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 593 Brazil Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 594 Brazil Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 595 Brazil Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 596 Brazil Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 597 Brazil Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 598 Brazil Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 599 Brazil Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 600 Brazil Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 601 Brazil Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 602 Brazil Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 603 Argentina Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 604 Argentina Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 605 Argentina Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 606 Argentina Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 607 Argentina Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 608 Argentina Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 609 Argentina Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 610 Argentina Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 611 Argentina Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 612 Argentina Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 613 Argentina Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 614 Argentina Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 615 Argentina Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 616 Argentina Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 617 Argentina Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 618 Argentina Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 619 rest of south america Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

Liste des figures

FIGURE 1 Global VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION

FIGURE 2 GLOBAL VIRAL VECTOR PURIFICATION MARKET: DATA TRIANGULATION

FIGURE 3 global Viral vector purification market: DROC ANALYSIS

FIGURE 4 Global Viral vector purification market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global Viral vector purification market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Viral vector purification market: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Viral vector purification market: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL VIRAL VECTOR PURIFICATION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL VIRAL VECTOR PURIFICATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL viral vector purification market: MARKET application COVERAGE GRID

FIGURE 11 Global Viral vector purification market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Viral vector purification market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 Availability of diverse range of innovative solutions for vector purification is DRIVing THE global Viral vector purification market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 products SEGMENT is expected to account for the largest share of the global VIRAL VECTOR PURIFICATION MARKET in 2021 & 2028

FIGURE 15 ASIA-PACIFIC is the fastest growing market FOR the Viral vector purification MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF global viral vector purification market

FIGURE 17 Estimated Number of New Cases in MALE AND FEMALE (ALL AGE GROUP) WORLDWIDE in 2018

FIGURE 1 Global Viral vector purification market: By product & services, 2020

FIGURE 2 Global Viral vector purification market: By product & services, 2021-2028 (USD Million)

FIGURE 3 Global Viral vector purification market: By product & services, CAGR (2021-2028)

FIGURE 4 Global Viral vector purification market: By product & services, LIFELINE CURVE

FIGURE 5 Global Viral vector purification market: By purification technique, 2020

FIGURE 6 Global Viral vector purification market: By purification technique, 2021-2028 (USD Million)

FIGURE 7 Global Viral vector purification market: By purification technique, CAGR (2021-2028)

FIGURE 8 Global Viral vector purification market: By purification technique, LIFELINE CURVE

FIGURE 9 Global Viral vector purification market: By type, 2020

FIGURE 10 Global Viral vector purification market: By type, 2021-2028 (USD Million)

FIGURE 11 Global Viral vector purification market: By type, CAGR (2021-2028)

FIGURE 12 Global Viral vector purification market: By type, LIFELINE CURVE

FIGURE 13 Global Viral vector purification market: By workflow, 2020

FIGURE 14 Global Viral vector purification market: By workflow, 2021-2028 (USD Million)

FIGURE 15 Global Viral vector purification market: By workflow, CAGR (2021-2028)

FIGURE 16 Global Viral vector purification market: By workflow, LIFELINE CURVE

FIGURE 17 Global Viral vector purification market: By scale of operation, 2020

FIGURE 18 Global Viral vector purification market: By scale of operation, 2021-2028 (USD Million)

FIGURE 19 Global Viral vector purification market: By scale of operation, CAGR (2021-2028)

FIGURE 20 Global Viral vector purification market: By scale of operation, LIFELINE CURVE

FIGURE 21 Global Viral vector purification market: By delivery mode, 2020

FIGURE 22 Global Viral vector purification market: By delivery mode, 2021-2028 (USD Million)

FIGURE 23 Global Viral vector purification market: By delivery mode, CAGR (2021-2028)

FIGURE 24 Global Viral vector purification market: By delivery mode, LIFELINE CURVE

FIGURE 25 Global Viral vector purification market: By disease indication, 2020

FIGURE 26 Global Viral vector purification market: By disease indication, 2021-2028 (USD Million)

FIGURE 27 Global Viral vector purification market: By disease indication, CAGR (2021-2028)

FIGURE 28 Global Viral vector purification market: By disease indication, LIFELINE CURVE

FIGURE 29 Global Viral vector purification market: By Application, 2020

FIGURE 30 Global Viral vector purification market: By Application, 2021-2028 (USD Million)

FIGURE 31 Global Viral vector purification market: By Application, CAGR (2021-2028)

FIGURE 32 Global Viral vector purification market: By Application, LIFELINE CURVE

FIGURE 33 Global Viral vector purification market: By end user, 2020

FIGURE 34 Global Viral vector purification market: By end user, 2021-2028 (USD Million)

FIGURE 35 Global Viral vector purification market: By end user, CAGR (2021-2028)

FIGURE 36 Global Viral vector purification market: By end user, LIFELINE CURVE

FIGURE 37 GLobal Viral Vector Purification MARKET: SNAPSHOT (2019)

FIGURE 38 global Viral Vector Purification MARKET: BY COUNTRY (2019)

FIGURE 39 global Viral Vector Purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 global Viral Vector Purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 41 global Viral Vector Purification MARKET: BY type (2020-2028)

FIGURE 42 North America viral vector purification MARKET: SNAPSHOT (2020)

FIGURE 43 North America viral vector purification MARKET: BY COUNTRY (2020)

FIGURE 44 North America viral vector purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 45 North America viral vector purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 46 North America viral vector purification MARKET: BY type (2021-2028)

FIGURE 47 Europe viral vector purification MARKET: SNAPSHOT (2020)

FIGURE 48 Europe viral vector purification MARKET: BY COUNTRY (2020)

FIGURE 49 Europe viral vector purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 50 Europe viral vector purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 51 Europe viral vector purification MARKET: BY type (2021-2028)

FIGURE 52 Asia-Pacific viral vector purification MARKET: SNAPSHOT (2020)

FIGURE 53 Asia-Pacific viral vector purification MARKET: BY COUNTRY (2020)

FIGURE 54 Asia-Pacific viral vector purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 55 Asia-Pacific viral vector purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 56 Asia-Pacific viral vector purification MARKET: BY type (2021-2028)

FIGURE 57 MIDDLE EAST & AFRICa viral vector purification MARKET: SNAPSHOT (2020)

FIGURE 58 MIDDLE EAST & AFRICa viral vector purification MARKET: BY COUNTRY (2020)

FIGURE 59 MIDDLE EAST & AFRICa viral vector purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 60 MIDDLE EAST & AFRICa viral vector purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 61 MIDDLE EAST & AFRICa viral vector purification MARKET: BY type (2021-2028)

FIGURE 62 South America viral vector purification MARKET: SNAPSHOT (2020)

FIGURE 63 South America viral vector purification MARKET: BY COUNTRY (2020)

FIGURE 64 South America viral vector purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 65 South America viral vector purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 66 South America viral vector purification MARKET: BY type (2021-2028)

FIGURE 67 Global Viral Vector Purification market: company share 2020 (%)

FIGURE 68 North America Viral Vector Purification Market: company share 2020 (%)

FIGURE 69 EUROPE Viral Vector Purification Market: company share 2020 (%)

FIGURE 70 ASIA-PACIFIC Viral Vector Purification Market: company share 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The Viral Vector Purification Market size will be worth USD 2,086.99 million during the forecast period.
The Viral Vector Purification Market growth rate is 14.2% during the forecast period.
The Increasing Demand for Gene Therapy for Chronic Illnesses and Advancements in Biotechnology Improving Efficiency and Scalability are the growth drivers of the Viral Vector Purification Market.
The roduct and services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user are the factors on which the Viral Vector Purification Market research is based.
The major companies in the Viral Vector Purification Market are Applied Biological Materials Inc. (Canada), Creative Biolabs (U.S.), Bio-Rad Laboratories, Inc. (U.S.), SIRION BIOTECH GmbH (Germany), Merck KGaA (Gemrany), FUJIFILM Diosynth Biotechnologies (U.S.), Batavia Biosciences B.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Addgene (U.S.), IDT Biologika (Germany), ProBioGen AG (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Waisman Biomanufacturing (U.S.), Creative Biogene (U.S.), Aldevron (U.S.), uniQure N.V. (Netherlands), Cytiva (U.S.) and Sartorius BIA Separations (Solvenia).

Parcourir les pages associées

Banner